Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70 - PubMed (original) (raw)

Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70

C L Reading et al. Proc Natl Acad Sci U S A. 1980 Oct.

Abstract

Variant sublines of the murine lymphosarcoma RAW117 have been derived by sequential cycles of intravenous inoculation of cells and harvesting of solid liver tumors in syngeneic BALB/c mice [Brunson K. W. & Nicolson, G. L. (1978) J. Natl. Cancer Inst. 61, 1499-1503] and also by sequential removal of lectin-reactive cells via repeated adsorption on immobilized-lectins [Reading, C. L. Belloni, P. N. & Nicolson, G. L. (1980) J. Natl. Cancer Inst. 64, 1241-1249]. These cell sublines and their clones were analyzed for abilities to form gross liver tumor metastases after injection intravenously or subcutaneously into syngeneic mice, and this response was related to certain cell surface properties including quantities of viral antigens and lectin-binding sites, exposure of specific cell surface proteins, and quantities of cell surface glycoproteins visualized in gels with 125I-labeled lectins or antibodies. Consistent differences were obtained between RAW117 sublines of low and high malignancy with respect to the amounts or exposures of cell surface glycoprotein components of Mr approximately 70,000 or 69,000 and 71,000, depending on the gel system. Competition radioimmunoassays for RNA tumor virus antigens in the RAW117 lines and clones indicated the presence of Moloney murine leukemic virus antigens gp70, p30, and p12. Enhanced malignancy and metastasis to liver was accompanied by decreases in the cellular contents of viral antigens and loss of gp70 cell surface exposure. Analysis of several clones obtained from sublines selected in vivo and in vitro for high or low malignancy confirmed the inverse relationship between metastasis and expression of gp70 in this system.

PubMed Disclaimer

Cited by

Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.
Joshi SS, Messbarger LJ, Hao W. Joshi SS, et al. Clin Exp Metastasis. 1994 Jan;12(1):37-46. doi: 10.1007/BF01784332. Clin Exp Metastasis. 1994. PMID: 8287619
The British Association for Cancer Research, 23rd annual general meeting. Edinburgh 29--31 March 1982. Abstracts.
[No authors listed] [No authors listed] Br J Cancer. 1982 Sep;46(3):459-516. doi: 10.1038/bjc.1982.227. Br J Cancer. 1982. PMID: 7126433 Free PMC article. No abstract available.
Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor.
Harris JF, Chambers AF, Hill RP, Ling V. Harris JF, et al. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5547-51. doi: 10.1073/pnas.79.18.5547. Proc Natl Acad Sci U S A. 1982. PMID: 6957880 Free PMC article.
Experimental systems for analysis of the malignant phenotype.
Poste G. Poste G. Cancer Metastasis Rev. 1982;1(2):141-99. doi: 10.1007/BF00048224. Cancer Metastasis Rev. 1982. PMID: 6764376 Review.

References

1. Cancer Res. 1967 May;27(5):962-7 - PubMed
1. Science. 1970 Jan 2;167(3914):72-4 - PubMed
1. J Exp Med. 1971 Jun 1;133(6):1334-55 - PubMed
1. J Exp Med. 1972 Mar 1;135(3):503-15 - PubMed
1. Biochemistry. 1973 Mar 27;12(7):1312-23 - PubMed

Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70 - PubMed (original) (raw)